![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
D Thuringer and D Escande
Rhone-Poulenc Sante, Centre de Recherche de Vitry, Vitry-sur-Seine, France.
The mechanism whereby RP 49356, a novel potassium channel opener, activates ATP-sensitive K+ channels (K+-ATP channels) in isolated cardiac cells was investigated with the patch-clamp technique. When directly applied onto the inner face of an inside-out membrane patch, RP 49356 (300 microM) had no effect on K+ channels opened in an ATP- free solution. In contrast, the same concentration of the drug reactivated K+-ATP channels that had experienced spontaneous "run-down" of their activity following long recording periods. In cell-attached experiments, externally applied RP 49356 (300 microM) opened K+-ATP channels at 35 degrees in spite of the high intracellular ATP concentration, which was sufficient to prevent channel openings in the absence of the drug. In control conditions, the dose-response relation for ATP closing the channels had a Hill coefficient of 2.37 and a half- inhibition concentration of 56 microM. With 30 microM RP 49356 present in the intracellular medium, the slope factor of this relation was unchanged but the curve was shifted to the right, with a half- inhibition concentration of 515 microM. Conversely, the dose-response relation of RP 49356 activating K+-ATP channels was shifted to the right in a parallel manner under the influence of increasing concentrations of ATP. It is concluded that RP 49356 acts on cardiac K+- ATP channels by decreasing their sensitivity to ATP. Our results are consistent with an apparent competition between ATP and RP 49356.
This article has been cited by other articles:
|
|
 |
|
  T. Krauter, J. P. Ruppersberg, and T. Baukrowitz Phospholipids as Modulators of KATP Channels: Distinct Mechanisms for Control of Sensitivity to Sulphonylureas, K+ Channel Openers, and ATP Mol. Pharmacol., April 16, 2001; 59(5): 1086 - 1093. [Abstract] [Full Text]
|
|
|
|
 |
|
 L. Aguilar-Bryan and J. Bryan Molecular Biology of Adenosine Triphosphate-Sensitive Potassium Channels Endocr. Rev., April 1, 1999; 20(2): 101 - 135. [Abstract] [Full Text]
|
|
|
|
 |
|
 T. Haruna, M. Horie, I. Kouchi, R. Nawada, K. Tsuchiya, M. Akao, H. Otani, T. Murakami, and S. Sasayama Coordinate Interaction Between ATP-Sensitive K+ Channel and Na+,K+-ATPase Modulates Ischemic Preconditioning Circulation, December 22, 1998; 98(25): 2905 - 2910. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. S Davie and N. B Standen Enhancement of the vasorelaxant potency of nicorandil by metabolic inhibition and adenosine in the pig coronary artery Cardiovasc Res, March 1, 1998; 37(3): 791 - 798. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Yokoshiki, Y. Katsube, M. Sunagawa, and N. Sperelakis The Novel Calcium Sensitizer Levosimendan Activates the ATP-Sensitive K+ Channel in Rat Ventricular Cells J. Pharmacol. Exp. Ther., October 1, 1997; 283(1): 375 - 383. [Abstract] [Full Text]
|
|
|
|
 |
|
 A. Babenko and G. Vassort Enhancement of the ATP-Sensitive K+ Current by Extracellular ATP in Rat Ventricular Myocytes : Involvement of Adenylyl Cyclase–Induced Subsarcolemmal ATP Depletion Circ. Res., April 19, 1997; 80(4): 589 - 600. [Abstract] [Full Text]
|
|
|
|
 |
|
 K. D. Garlid, P. Paucek, V. Yarov-Yarovoy, X. Sun, and P. A. Schindler The Mitochondrial K[IMAGE] Channel as a Receptor for Potassium Channel Openers J. Biol. Chem., April 12, 1996; 271(15): 8796 - 8799. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. L. Maskal, N. M. Cohen, P.-W. Hsia, A. S. Wechsler, and R. J. Damiano Jr. HYPERPOLARIZED CARDIAC ARREST WITH A POTASSIUM-CHANNEL OPENER, APRIKALIM J. Thorac. Cardiovasc. Surg., October 1, 1995; 110(4): 1083 - 1095. [Abstract] [Full Text]
|
|
 |
 |
 |
|
 |
 |
 |
